BACKGROUND & AIMS: An association between gastric cancer and the rs2294008 (C>T) polymorphism in the prostate stem cell antigen (PSCA) gene has been reported for several Asian populations. We set out to determine whether such an association exists in white individuals. METHODS: We genotyped 166 relatives of gastric cancer patients, including 43 Helicobacter pylori-infected subjects with hypochlorhydria and gastric atrophy, 65 infected subjects without these abnormalities, 58 H pylori-negative relatives, and 100 population controls. Additionally, a population-based study of chronic atrophic gastritis provided 533 cases and 1054 controls. We then genotyped 2 population-based, case-control studies of upper gastrointestinal cancer: the first included 312 gastric cancer cases and 383 controls; the second included 309 gastric cancer cases, 159 esophageal cancer cases, and 211 controls. Odds ratios were computed from logistic models and adjusted for confounding variables. RESULTS: Carriage of the risk allele (T) of rs2294008 in PSCA was associated with chronic atrophic gastritis (adjusted odds ratio [OR], 1.5; 95% confidence interval [CI]: 1.1-1.9) and noncardia gastric cancer (OR, 1.9; 95% CI: 1.3-2.8). The association was strongest for the diffuse histologic type (OR, 3.2; 95% CI: 1.2-10.7). An inverse association was observed between carriage of the risk allele and gastric cardia cancer (OR, 0.5; 95% CI: 0.3-0.9), esophageal adenocarcinoma (OR, 0.5; 95% CI: 0.3-0.9), and esophageal squamous cell carcinoma (OR, 0.4; 95% CI: 0.2-0.9). CONCLUSIONS: The rs2294008 polymorphism in PSCA increases the risk of noncardia gastric cancer and its precursors in white individuals but protects against proximal cancers.
BACKGROUND & AIMS: An association between gastric cancer and the rs2294008 (C>T) polymorphism in the prostate stem cell antigen (PSCA) gene has been reported for several Asian populations. We set out to determine whether such an association exists in white individuals. METHODS: We genotyped 166 relatives of gastric cancer patients, including 43 Helicobacter pylori-infected subjects with hypochlorhydria and gastric atrophy, 65 infected subjects without these abnormalities, 58 H pylori-negative relatives, and 100 population controls. Additionally, a population-based study of chronic atrophic gastritis provided 533 cases and 1054 controls. We then genotyped 2 population-based, case-control studies of upper gastrointestinal cancer: the first included 312 gastric cancer cases and 383 controls; the second included 309 gastric cancer cases, 159 esophageal cancer cases, and 211 controls. Odds ratios were computed from logistic models and adjusted for confounding variables. RESULTS: Carriage of the risk allele (T) of rs2294008 in PSCA was associated with chronic atrophic gastritis (adjusted odds ratio [OR], 1.5; 95% confidence interval [CI]: 1.1-1.9) and noncardia gastric cancer (OR, 1.9; 95% CI: 1.3-2.8). The association was strongest for the diffuse histologic type (OR, 3.2; 95% CI: 1.2-10.7). An inverse association was observed between carriage of the risk allele and gastric cardia cancer (OR, 0.5; 95% CI: 0.3-0.9), esophageal adenocarcinoma (OR, 0.5; 95% CI: 0.3-0.9), and esophageal squamous cell carcinoma (OR, 0.4; 95% CI: 0.2-0.9). CONCLUSIONS: The rs2294008 polymorphism in PSCA increases the risk of noncardia gastric cancer and its precursors in white individuals but protects against proximal cancers.
Authors: John S Lam; Joyce Yamashiro; I Peter Shintaku; Robert L Vessella; Robert B Jenkins; Steve Horvath; Jonathan W Said; Robert E Reiter Journal: Clin Cancer Res Date: 2005-04-01 Impact factor: 12.531
Authors: Michael S D Kormann; David Carr; Norman Klopp; Thomas Illig; Wolfgang Leupold; Christian Fritzsch; Stephan K Weiland; Erika von Mutius; Michael Kabesch Journal: Am J Respir Crit Care Med Date: 2005-03-11 Impact factor: 21.405
Authors: P Argani; C Rosty; R E Reiter; R E Wilentz; S R Murugesan; S D Leach; B Ryu; H G Skinner; M Goggins; E M Jaffee; C J Yeo; J L Cameron; S E Kern; R H Hruban Journal: Cancer Res Date: 2001-06-01 Impact factor: 12.701
Authors: Emad M El-Omar; Charles S Rabkin; Marilie D Gammon; Thomas L Vaughan; Harvey A Risch; Janet B Schoenberg; Janet L Stanford; Susan T Mayne; James Goedert; William J Blot; Joseph F Fraumeni; Wong-Ho Chow Journal: Gastroenterology Date: 2003-05 Impact factor: 22.682
Authors: L A Anderson; S J Murphy; B T Johnston; R G P Watson; H R Ferguson; K B Bamford; A Ghazy; P McCarron; J McGuigan; J V Reynolds; H Comber; L J Murray Journal: Gut Date: 2007-11-19 Impact factor: 23.059
Authors: N J Talley; A R Zinsmeister; A Weaver; E P DiMagno; H A Carpenter; G I Perez-Perez; M J Blaser Journal: J Natl Cancer Inst Date: 1991-12-04 Impact factor: 13.506
Authors: M H Derakhshan; R Malekzadeh; H Watabe; A Yazdanbod; V Fyfe; A Kazemi; N Rakhshani; R Didevar; M Sotoudeh; A A Zolfeghari; K E L McColl Journal: Gut Date: 2007-10-26 Impact factor: 23.059
Authors: Hannes Helgason; Thorunn Rafnar; Halla S Olafsdottir; Jon G Jonasson; Asgeir Sigurdsson; Simon N Stacey; Adalbjorg Jonasdottir; Laufey Tryggvadottir; Kristin Alexiusdottir; Asgeir Haraldsson; Louise le Roux; Julius Gudmundsson; Hrefna Johannsdottir; Asmundur Oddsson; Arnaldur Gylfason; Olafur T Magnusson; Gisli Masson; Thorvaldur Jonsson; Halla Skuladottir; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Patrick Sulem; Kari Stefansson Journal: Nat Genet Date: 2015-06-22 Impact factor: 38.330
Authors: B M Wolpin; E M O'Reilly; Y J Ko; L S Blaszkowsky; M Rarick; C M Rocha-Lima; P Ritch; E Chan; J Spratlin; T Macarulla; E McWhirter; D Pezet; M Lichinitser; L Roman; A Hartford; K Morrison; L Jackson; M Vincent; L Reyno; M Hidalgo Journal: Ann Oncol Date: 2013-02-28 Impact factor: 32.976